A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research

 

Show simple item record

dc.contributor.author de Vries, Jantina
dc.contributor.author Abayomi, Akin
dc.contributor.author Brandful, James
dc.contributor.author Littler, Katherine
dc.contributor.author Madden, Ebony
dc.contributor.author Marshall, Patricia
dc.contributor.author Ouwe Missi Oukem-Boyer, Odile
dc.contributor.author Seeley, Janet
dc.date.accessioned 2015-01-21T12:10:08Z
dc.date.available 2015-01-21T12:10:08Z
dc.date.issued 2014-08-07
dc.identifier.citation BMC Medical Ethics. 2014 Aug 07;15(1):60 en_ZA
dc.identifier.issn 1472-6939 en_ZA
dc.identifier.uri http://dx.doi.org/10.1186/1472-6939-15-60
dc.identifier.uri http://hdl.handle.net/11427/12285
dc.identifier.uri http://hdl.handle.net/11427/12285
dc.identifier.uri http://dx.doi.org/10.1186/1472-6939-15-60
dc.description.abstract Background: The rise of genomic studies in Africa – not least due to projects funded under H3Africa – is associated with the development of a small number of biorepositories across Africa. For the ultimate success of these biorepositories, the creation of cell lines including those from selected H3Africa samples would be beneficial. In this paper, we map ethical challenges in the creation of cell lines. Discussion: The first challenge we identified relates to the moral status of cells living in culture. There is no doubt that cells in culture are alive, and the question is how this characteristic is relevant to ethical decision-making. The second challenge relates to the fact that cells in culture are a source of cell products and mitochondrial DNA. In combination with other technologies, cells in culture could also be used to grow human tissue. Whilst on the one hand, this feature increases the potential utility of the sample and promotes science, on the other it also enables further scientific work that may not have been specifically consented to or approved. The third challenge relates to ownership over samples, particularly in cases where cell lines are created by a biobank, and in a different country than where samples were collected. Relevant questions here concern the export of samples, approval of secondary use and the acceptability of commercialisation. A fourth challenge relates to perceptions of blood and bodily integrity, which may be particularly relevant for African research participants from certain cultures or backgrounds. Finally, we discuss challenges around informed consent and ethical review. Summary: In this paper, we sought to map the myriad of ethical challenges that need to be considered prior to making cell line creation a reality in the H3Africa project. Considering the relative novelty of this practice in Africa, such challenges will need to be considered, discussed and potentially be resolved before cell line creation in Africa becomes financially feasible and sustainable. We suggest that discussions need to be undertaken between stakeholders internationally, considering the international character of the H3Africa project. We also map out avenues for empirical research. en_ZA
dc.publisher BioMed Central en_ZA
dc.rights Creative Commons Attribution 4.0 International (CC BY 4.0) *
dc.rights.uri http://creativecommons.org/licenses/by/4.0/ en_ZA
dc.source BMC Medical Ethics en_ZA
dc.source.uri http://www.biomedcentral.com/1472-6939
dc.subject.other Cell lines en_ZA
dc.subject.other H3Africa en_ZA
dc.title A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research en_ZA
dc.type Journal Article en_ZA
dc.date.updated 2015-01-15T17:53:42Z
dc.language.rfc3066 en
dc.rights.holder de Vries et al.; licensee BioMed Central Ltd.
uct.type.publication Research en_ZA
uct.type.resource Article en_ZA
dc.publisher.institution University of Cape Town
dc.publisher.faculty Faculty of Health Sciences en_ZA
dc.publisher.department Department of Medicine en_ZA
uct.type.filetype
uct.type.filetype Text
uct.type.filetype Image
dc.identifier.apacitation de Vries, J., Abayomi, A., Brandful, J., Littler, K., Madden, E., Marshall, P., ... Seeley, J. (2014). A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research. <i>BMC Medical Ethics</i>, http://hdl.handle.net/11427/12285 en_ZA
dc.identifier.chicagocitation de Vries, Jantina, Akin Abayomi, James Brandful, Katherine Littler, Ebony Madden, Patricia Marshall, Odile Ouwe Missi Oukem-Boyer, and Janet Seeley "A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research." <i>BMC Medical Ethics</i> (2014) http://hdl.handle.net/11427/12285 en_ZA
dc.identifier.vancouvercitation de Vries J, Abayomi A, Brandful J, Littler K, Madden E, Marshall P, et al. A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research. BMC Medical Ethics. 2014; http://hdl.handle.net/11427/12285. en_ZA
dc.identifier.ris TY - Journal Article AU - de Vries, Jantina AU - Abayomi, Akin AU - Brandful, James AU - Littler, Katherine AU - Madden, Ebony AU - Marshall, Patricia AU - Ouwe Missi Oukem-Boyer, Odile AU - Seeley, Janet AB - Background: The rise of genomic studies in Africa – not least due to projects funded under H3Africa – is associated with the development of a small number of biorepositories across Africa. For the ultimate success of these biorepositories, the creation of cell lines including those from selected H3Africa samples would be beneficial. In this paper, we map ethical challenges in the creation of cell lines. Discussion: The first challenge we identified relates to the moral status of cells living in culture. There is no doubt that cells in culture are alive, and the question is how this characteristic is relevant to ethical decision-making. The second challenge relates to the fact that cells in culture are a source of cell products and mitochondrial DNA. In combination with other technologies, cells in culture could also be used to grow human tissue. Whilst on the one hand, this feature increases the potential utility of the sample and promotes science, on the other it also enables further scientific work that may not have been specifically consented to or approved. The third challenge relates to ownership over samples, particularly in cases where cell lines are created by a biobank, and in a different country than where samples were collected. Relevant questions here concern the export of samples, approval of secondary use and the acceptability of commercialisation. A fourth challenge relates to perceptions of blood and bodily integrity, which may be particularly relevant for African research participants from certain cultures or backgrounds. Finally, we discuss challenges around informed consent and ethical review. Summary: In this paper, we sought to map the myriad of ethical challenges that need to be considered prior to making cell line creation a reality in the H3Africa project. Considering the relative novelty of this practice in Africa, such challenges will need to be considered, discussed and potentially be resolved before cell line creation in Africa becomes financially feasible and sustainable. We suggest that discussions need to be undertaken between stakeholders internationally, considering the international character of the H3Africa project. We also map out avenues for empirical research. DA - 2014-08-07 DB - OpenUCT DO - 10.1186/1472-6939-15-60 DP - University of Cape Town J1 - BMC Medical Ethics LK - https://open.uct.ac.za PB - University of Cape Town PY - 2014 SM - 1472-6939 T1 - A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research TI - A perpetual source of DNA or something really different: ethical issues in the creation of cell lines for African genomics research UR - http://hdl.handle.net/11427/12285 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International (CC BY 4.0) Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International (CC BY 4.0)